Group 1 - The company Minsheng Health (301507) plans to participate as a strategic investor in the initial public offering (IPO) of Jiyuan Group (603262) with a subscription amount not exceeding RMB 15 million [1] - Jiyuan Group has received approval from the China Securities Regulatory Commission for its IPO registration [1] - The final subscription amount will be determined based on the final allocation results announced by Jiyuan Group and its sponsor [1] Group 2 - The company's board of directors has approved the relevant proposals and authorized the management to handle related matters [1] - This external investment falls within the decision-making authority of the board and does not require submission for shareholder meeting approval [1]
民生健康：拟参与技源集团1500万元战略配售